Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.
Menu

Biomarin Pharmaceuticals (BMRN)

Biomarin Pharmaceuticals (BMRN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
BioMarin to Host Fourth Quarter and Full-Year 2025 Financial Results Conference Call and Webcast on Monday, February 23, 2026, at 4:30pm ET PR Newswire - Tue Feb 17, 8:00AM CST

SAN RAFAEL, Calif. , Feb. 17, 2026 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that Alexander Hardy, President and Chief Executive Officer of BioMarin, will host a...

BMRN : 63.42 (+2.57%)
BioMarin Announces Closing of Private Offering of Senior Notes PR Newswire - Thu Feb 12, 3:05PM CST

SAN RAFAEL, Calif. , Feb. 12, 2026 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) ("BioMarin") announced today that it closed its previously announced offering of $850 million of 5.500%...

BMRN : 63.42 (+2.57%)
BioMarin Announces Pricing of Private Offering of Senior Notes and Completion of Syndication of New Senior Secured Term Loan Facility PR Newswire - Thu Jan 29, 3:05PM CST

SAN RAFAEL, Calif. , Jan. 29, 2026 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) ("BioMarin") announced today that it priced its previously announced offering of $850 million of 5.500%...

BMRN : 63.42 (+2.57%)
BioMarin Announces Proposed Private Offering of Senior Notes and Syndication of New Senior Secured Term Loan Facility PR Newswire - Mon Jan 26, 6:45AM CST

SAN RAFAEL, Calif. , Jan. 26, 2026 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) ("BioMarin") announced today that it intends to offer, subject to market and other conditions, $850...

BMRN : 63.42 (+2.57%)
BioMarin Appoints Arpit Davé Chief Digital and Information Officer PR Newswire - Mon Jan 12, 3:05PM CST

Mr. Davé Brings more than 20 Years of Experience in Creating Enterprise Value through Digital Transformation, Information Technology and Artificial Intelligence across the Biopharmaceutical Industry

BMRN : 63.42 (+2.57%)
APPN
1 of Wall Street’s Favorite Stock with Exciting Potential and 2 We Find Risky StockStory - Thu Jan 8, 10:35PM CST

1 of Wall Street’s Favorite Stock with Exciting Potential and 2 We Find Risky

APPN : 24.54 (+2.00%)
PVH : 69.67 (+0.48%)
BMRN : 63.42 (+2.57%)
BioMarin to Present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, at 11:15 am PT / 2:15 pm ET, in San Francisco, CA PR Newswire - Thu Jan 8, 3:05PM CST

SAN RAFAEL, Calif. , Jan. 8, 2026 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that Alexander Hardy, President and Chief Executive Officer of BioMarin, will present...

BMRN : 63.42 (+2.57%)
Veeva and BioMarin Form Long-Term Strategic Partnership PR Newswire - Thu Jan 8, 7:30AM CST

Partnership to help BioMarin increase speed and efficiency  in developing and commercializing innovative therapies

VEEV : 182.57 (+0.73%)
BMRN : 63.42 (+2.57%)
Amicus Therapeutics Investment Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Amicus Therapeutics, Inc. - FOLD Business Wire - Fri Dec 26, 2025

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti , LLC (“KSF”) are investigating the proposed sale of Amicus Therapeutics...

FOLD : 14.35 (+0.07%)
BMRN : 63.42 (+2.57%)
BMRN
BioMarin Pharmaceutical (BMRN) Stock Is Up, What You Need To Know StockStory - Tue Dec 23, 2025

BioMarin Pharmaceutical (BMRN) Stock Is Up, What You Need To Know

BMRN : 63.42 (+2.57%)

Barchart Exclusives

S&P Futures Muted With U.S. PCE Inflation and GDP Data in Focus Barchart - 24 minutes ago
March S&P 500 E-Mini futures (ESH26) are trending up +0.01% this morning as investors assess the potential impact of conflict in the Middle East and await a raft of U.S. economic data, with particular attention on the Fed’s favorite inflation gauge and the first estimate of fourth-quarter GDP. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot